At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 102 enrolled
Drug / intervention
Fluticasone Furoate Nasal Spray +1 moredrug
Likely dose
Fluticasone Furoate Nasal Spray 110mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multicentre Study to Evaluate the Efficacy and Safety of Once-daily Intranasal Administration of Fluticasone Furoate Nasal Spray 110 mcg for 4 Weeks in Adults and Adolescents With Irritant (Non-Allergic) Rhinitis
In Brief
A Phase 2 clinical trial evaluating Fluticasone Furoate Nasal Spray and Placebo Nasal Spray for Rhinitis, Allergic, Perennial. Completed, enrolled 102 participants across 5 sites.
Detailed Summary
The purpose of this pilot study is to compare the effects (effectiveness and safety)of an intranasal corticosteroid (fluticasone furoate nasal spray \[FFNS\]) with a placebo nasal spray for the treatment of irritant (non-allergic) rhinitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRhinitis, Allergic, Perennial
CountriesThailand
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2008
First PostedAug 2008
Primary CompletionFeb 2009
TodayJul 2026
First PostedAug 8, 2008
Enrollment StartMar 1, 2008
Primary CompletionFeb 1, 2009
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 17.9 years ago
Interventions
Fluticasone Furoate Nasal Spraydrug
Fluticasone furoate nasal spray 110mcg intranasally once daily for 4 weeks
Placebo Nasal Sprayother
Matching placebo nasal spray intranasally once daily for 4 weeks